Cambridge Cognition Holdings PLC bags new contract worth £750,000 | Kalkine Market Update UK |

October 08, 2020 04:42 AM PDT | By Team Kalkine Media

Google News:

Recent News

SLV ETF inflows surge as silver price rally accelerates

RBI turns neutral after sharp rate cut; ING expects another easing lat...

AB Launches on Binance

Trade war poses greater threat than COVID for emerging market central...

Cambridge Cognition Holdings Plc (LON:COG) has bagged a new deal for delivering cognitive tests and eCOA for an Alzheimer's trial. The trials of Alzheimer's have seen substantial disappointments in the past some years, hence this pharma client of the company is taking a new approach with a cutting-edge part-virtual clinical. This trial combines remote testing as well as in-person process.

The company is expected to be getting a substantial amount of the total contract value worth around £750,000 in 2021 and all the amount in over two years. COG shares at GMT 09:52 AM on 7 October 2020, were trading at GBX 52.00, higher by 3.50 points or 7.22% against the previous day’s closing price.

Yourgene Health Plc bags new contract for NIPT

Yourgene Health Plc (LON:YGEN) has bagged a new contract from the famed St George's NHS Trust Foundation in Tooting, South London. The contract is for NIPT (non-invasive prenatal testing) using the company’s newly launched IONA® Nx NIPT Workflow.

The company has bagged the contract through a competitive tender process, and it will widen its current alliance with St George's for another three years. YGEN shares on 7 October 2020, at GMT 09:50 AM, were trading at GBP 20.00, unchanged against the previous day’s closing price.

Omega Diagnostics Group Plc in a group bags a contract for UK-Rapid Test

Omega Diagnostics Group Plc (LON:ODX) in a group has bagged UK Government contracts for UK-Rapid Test.

It is the UK Government's first order for one million COVID-19 the AbC-19™ Rapid test or the lateral flow antibody tests. The project is part of the government’s plan to roll-out COVID-19 observation studies to help build a case study of how the virus proliferated across the country.

ODX shares at GMT 09:50 AM, on 7 October 2020, were trading at GBX 107.50, up by 1.50 points or 1.42% against the last day’s closing price.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.